www.fdanews.com/articles/73052-edot-com-announces-term-sheet-to-acquire-nanoviricide
EDot.com Announces Term Sheet to Acquire NanoViricide
June 6, 2005
EDot.com announced the execution of a definitive term sheet to acquire 100 percent of the common stock of NanoViricide, a company engaged in the development of targeted nanomedicines that act like molecular Trojan horses to combat various viral infections, including HIV, HCV, Herpes, Asian (bird) Flu and Influenza.